HeartBeam and HeartNexus Partnership: 24/7 Remote Cardiology Services FAQ
Summary
HeartBeam Inc. has partnered with HeartNexus to provide 24/7 remote cardiology services using HeartBeam's patented 3D ECG technology, enabling patients to capture and transmit cardiac data for immediate interpretation by board-certified cardiologists outside traditional medical facilities.
What is the main purpose of the partnership between HeartBeam and HeartNexus?
The partnership enables HeartBeam to offer 24/7 cardiology reader services for patients experiencing cardiac symptoms outside traditional care settings, providing immediate ECG interpretation by board-certified cardiologists.
How does HeartBeam’s technology work for remote cardiac monitoring?
Patients can capture a 30-second, cable-free ECG recording using HeartBeam’s patented 3D technology when symptoms occur, then transmit the data to HeartNexus cardiologists for immediate interpretation.
What makes HeartBeam’s ECG technology unique?
HeartBeam’s technology is the first-ever cable-free device capable of collecting ECG signals in 3D from three non-coplanar directions and synthesizing the signals into a 12-lead ECG, designed for portable use wherever the patient is located.
Who are the key companies involved in this partnership?
HeartBeam Inc. (NASDAQ: BEAT), a medical technology company focused on cardiac care, and HeartNexus Inc., a network of board-certified cardiologists specializing in cardiac test interpretation, peer consultations, and telemedicine visits.
What are the regulatory approvals for HeartBeam’s technology?
HeartBeam’s 3D ECG technology received FDA clearance for arrhythmia assessment in December 2024, and the 12-Lead ECG synthesis software is currently under FDA review.
What are the main benefits of this partnership for patients?
The partnership makes medical-grade cardiac monitoring accessible beyond medical facilities, provides real-time cardiology feedback, and enables patients to capture ECG recordings anytime symptoms occur for immediate interpretation.
What future developments are planned for HeartBeam’s ecosystem?
The partnership expands HeartBeam’s ecosystem with future integration of AI wellness and wearable features, in addition to the current real-time cardiology feedback services.
Where can I find more information about HeartBeam and this partnership?
The full press release is available at https://ibn.fm/HqwuQ, and the latest news and updates relating to BEAT are available in the company’s newsroom at https://ibn.fm/BEAT.
What intellectual property does HeartBeam hold for this technology?
HeartBeam holds over 20 issued patents related to technology enablement for their 3D ECG platform technology.
How does this partnership advance HeartBeam’s mission?
According to CEO Robert Eno, working with HeartNexus accelerates HeartBeam’s mission to make medical-grade cardiac monitoring accessible beyond the walls of a medical facility and redefine the future of cardiac health management.
This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)
Article Control ID: 267398